Inventor · disambiguated record
Jiacheng Zhou
Also filed as: ZHOU JIACHENG
87 granted patents·30 pending applications·1,215 citations·filing 1998–2025
99Inventor score
Files withINCYTE CORP73BRISTOL MYERS SQUIBB PHARMA CO7RIB X PHARMACEUTICALS INC7ZHOU JIACHENG6INCYTE HOLDINGS CORP5
Top patents by PatentIndex Score
117 records- 0198US12084443B2Process of preparing a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2023·Granted Sep 10, 2024·5 cites·9 claims
- 0298US11760756B2Crystalline form of a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2021·Granted Sep 19, 2023·9 cites·46 claims
- 0398US11753406B2Salts of a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2020·Granted Sep 12, 2023·9 cites·23 claims
- 0498US11104682B2Salts of TAM inhibitorsINCYTE CORP·Filed 2020·Granted Aug 31, 2021·7 cites·35 claims
- 0598US9290506B2Processes for preparing JAK inhibitors and related intermediate compoundsINCYTE CORP·Filed 2015·Granted Mar 22, 2016·60 cites·1 claims
- 0698US9000161B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2013·Granted Apr 7, 2015·67 cites·25 claims
- 0798US8993582B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2013·Granted Mar 31, 2015·60 cites·1 claims
- 0898US8883806B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2013·Granted Nov 11, 2014·76 cites·3 claims
- 0998US8410265B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2010·Granted Apr 2, 2013·136 cites·4 claims
- 1097US11866451B2Salts and crystalline forms of a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2020·Granted Jan 9, 2024·7 cites·33 claims
- 1197US11780836B2Process of preparing a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2021·Granted Oct 10, 2023·8 cites·38 claims
- 1297US11377446B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2020·Granted Jul 5, 2022·8 cites·14 claims
- 1397US10858372B2Amorphous solid form of a BET protein inhibitorINCYTE CORP·Filed 2019·Granted Dec 8, 2020·10 cites·14 claims
- 1497US10189832B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2017·Granted Jan 29, 2019·23 cites·38 claims
- 1597US9487521B2Processes and intermediates for making a JAK inhibitorZHOU JIACHENG·Filed 2012·Granted Nov 8, 2016·74 cites·16 claims
- 1696US11905292B2Process and intermediates for preparing a JAK inhibitorINCYTE CORP·Filed 2021·Granted Feb 20, 2024·4 cites·69 claims
- 1796US11174257B2Salts of an FGFR inhibitorINCYTE CORP·Filed 2019·Granted Nov 16, 2021·21 cites·13 claims
- 1896US11091480B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2020·Granted Aug 17, 2021·8 cites·12 claims
- 1996US10975085B2Process for preparing a composition comprising an enantiomeric excess of greater than or equal to 90% of the (R)-enantiomer of a compound of formula IIIINCYTE HOLDINGS CORP·Filed 2019·Granted Apr 13, 2021·5 cites·8 claims
- 2096US10626114B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2018·Granted Apr 21, 2020·15 cites·31 claims
- 2196US10364248B2Processes for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidineINCYTE HOLDINGS CORP·Filed 2018·Granted Jul 30, 2019·5 cites·13 claims
- 2296US10329305B2Amorphous solid form of a BET protein inhibitorINCYTE CORP·Filed 2018·Granted Jun 25, 2019·16 cites·19 claims
- 2396US8420645B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameWENG LINGKAI·Filed 2009·Granted Apr 16, 2013·49 cites·16 claims
- 2496US7153960B2Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-onesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 26, 2006·29 cites·6 claims
- 2595US12030882B2Crystalline solid forms of a bet inhibitorINCYTE CORP·Filed 2022·Granted Jul 9, 2024·3 cites·15 claims
- 2695US12024517B2Salts of an FGFR inhibitorINCYTE CORP·Filed 2021·Granted Jul 2, 2024·3 cites·10 claims
- 2795US11866434B2Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereofINCYTE CORP·Filed 2021·Granted Jan 9, 2024·7 cites·41 claims
- 2895US11472801B2Crystalline forms of a FGFR inhibitor and processes for preparing the sameINCYTE CORP·Filed 2020·Granted Oct 18, 2022·9 cites·30 claims
- 2995US9908888B2Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidinesINCYTE HOLDINGS CORP·Filed 2016·Granted Mar 6, 2018·6 cites·8 claims
- 3095US8796319B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2011·Granted Aug 5, 2014·21 cites·68 claims
- 3195US6541639B2Efficient ligand-mediated Ullmann coupling of anilines and azolesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 1, 2003·92 cites·29 claims
- 3294US12071439B2Process and intermediates for preparing a JAK inhibitorINCYTE CORP·Filed 2022·Granted Aug 27, 2024·2 cites·31 claims
- 3394US11897889B2Process and intermediates for preparing a JAK1 inhibitorINCYTE CORP·Filed 2021·Granted Feb 13, 2024·2 cites·69 claims
- 3494US11084822B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2019·Granted Aug 10, 2021·7 cites·37 claims
- 3594US10723700B2Salts of an LSD1 inhibitorINCYTE CORP·Filed 2019·Granted Jul 28, 2020·7 cites·54 claims
- 3694US10336759B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2016·Granted Jul 2, 2019·18 cites·8 claims
- 3794US9862705B2Salts of a pim kinase inhibitorINCYTE CORP·Filed 2016·Granted Jan 9, 2018·13 cites·12 claims
- 3894US9802957B2Processes of preparing a JAK1 inhibitor and new forms theretoINCYTE CORP·Filed 2015·Granted Oct 31, 2017·28 cites·9 claims
- 3994US7148219B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2005·Granted Dec 12, 2006·28 cites·71 claims
- 4093US10968200B2Salts of an LSD1 inhibitor and processes for preparing the sameINCYTE CORP·Filed 2019·Granted Apr 6, 2021·5 cites·34 claims
- 4193US10633387B2Salts of TAM inhibitorsINCYTE CORP·Filed 2018·Granted Apr 28, 2020·10 cites·23 claims
- 4293US10329255B2Salts of an LSD1 inhibitorINCYTE CORP·Filed 2016·Granted Jun 25, 2019·15 cites·57 claims
- 4393US6969726B2Biaryl heterocyclic compounds and methods of making and using the sameRIB X PHARMACEUTICALS INC·Filed 2004·Granted Nov 29, 2005·44 cites·104 claims
- 4492US10899736B2Processes and intermediates for making a JAK inhibitorINCYTE CORP·Filed 2019·Granted Jan 26, 2021·7 cites·43 claims
- 4592US10450325B2Processes of preparing a JAK1 inhibitor and new forms theretoINCYTE CORP·Filed 2017·Granted Oct 22, 2019·11 cites·13 claims
- 4692US9718834B2Processes and intermediates for making a JAK inhibitorINCYTE CORP·Filed 2016·Granted Aug 1, 2017·10 cites·7 claims
- 4792US9321755B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2014·Granted Apr 26, 2016·15 cites·66 claims
- 4892US8901123B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameWENG LINGKAI·Filed 2013·Granted Dec 2, 2014·14 cites·3 claims
- 4991US10245265B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameINCYTE CORP·Filed 2016·Granted Apr 2, 2019·6 cites·24 claims
- 5091US6919451B2Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-onesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 19, 2005·25 cites·9 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jiacheng Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →